Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) major shareholder Guy Levy bought 500,000 shares of Parabilis Medicines stock in a transaction that occurred on Thursday, June 11th. The stock was purchased at an average cost of $20.00 per share, with a total value of $10,000,000.00. Following the completion of the acquisition, the insider directly owned 1,027,000 shares in the company, valued at $20,540,000. This represents a 94.88% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Parabilis Medicines Price Performance
NASDAQ PBLS opened at $27.76 on Thursday. Parabilis Medicines, Inc. has a 12 month low of $24.51 and a 12 month high of $34.47.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded shares of Parabilis Medicines to a “hold” rating in a research report on Saturday, June 20th.
See Also
- Five stocks we like better than Parabilis Medicines
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
